Scientific publisher Nature Publishing Group (NPG), UK, and BioCentury Publications, Inc., a source of biopharma business intelligence, have announced the inaugural SciBX Summit on Innovation in Drug Discovery & Development.
This unique Think Tank will be held in conjunction with EBD Group's BioPharma America meeting in Boston on September 21, 2012. It will seek to bring together key opinion leaders from academia, biotech, pharma and the investment community to build a roadmap for macrocycles and constrained peptides, which promise to reach therapeutic targets that have been inaccessible to existing drugs and biologics.
NPG and BioCentury, the co-publishers of SciBX: Science-Business eXchange, are convening a SciBX Think Tank of global leaders in the field: Bruce Booth, Partner at Atlas Venture; Spiros Liras, Head of Medicinal Chemistry in Cardiovascular, Metabolic and Endocrine Diseases at Pfizer Inc.; Barry Morgan, Vice President of Molecular Discovery Research at GlaxoSmithKline plc; Patrick Reid, Co-founder and Chief Scientific Officer , Head of Research & Development of PeptiDream Inc.; Tomi Sawyer, Chief Scientific Officer, SVP Drug Discovery & Innovative Technologies of Aileron Therapeutics Inc.; and Professor Gregory Verdine of Harvard Medical School and Third Rock Ventures.
The SciBX Think Tank will convene before the meeting to identify the essential next steps for translating these promising compounds into medicines for patients. The panel's final strategy recommendations will be presented to the SciBX Summit, along with presentations on the landscape, challenges and opportunities for this important technology.
The SciBX Summit findings will be published in a future edition of SciBX: Science Business eXchange. This journal was created in 2008 to marry the scientific acumen of NPG with the business intelligence of BioCentury.
The SciBX Summit will take place at 9 am September 21, at the Boston Westin Waterfront Hotel in conjunction with BioPharm America. The Summit is open to all registered participants at BioPharm America as well as attendees who register at the SciBX Summit website, http://www.nature.com/natureconferences/sidds/index.html.
